BETTERLIFE PHARMA INC.
Cash Flow Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-121.2K | $-6.3M | $-10.3M | $-1.1M | $341.4K | $1.4M | $-3.0M | $-120.1K |
| Depreciation & Amortization | — | — | $322 | $409 | — | — | — | — |
| Depreciation | — | — | $322 | $409 | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $52.1K | $5.0M | $5.9M | — | — | $14.7K | — | — |
| Net Cash from Operating Activities | $-395.6K | $-359.4K | $-163.9K | $-47.3K | $-31.6K | $-135.8K | $-107.8K | — |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | — | $-2.3K | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $360.5K | $379.7K | $240.2K | $47.3K | $30.0K | $122.9K | $106.1K | — |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — | — | — | — |